SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Revenue for the quarter ended  June 2024 of Rs. 14755.60 millions grew by 10.76 % from Rs. 13322.70 millions.Handsome Net Profit growth of 80.65% reported above the corresponding previous quarter figure of Rs. 1761.90 millions to Rs. 975.30 millions.OP of the company witnessed a marginal growth to 2945.70 millions from 1775.70 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 14755.60 13322.70 10.76 14755.60 13322.70 10.76 58740.60 51490.00 14.08
Other Income 31.40 118.50 -73.50 31.40 118.50 -73.50 313.20 35.40 784.75
PBIDT 2945.70 1775.70 65.89 2945.70 1775.70 65.89 10298.40 6678.80 54.20
Interest 126.90 142.90 -11.20 126.90 142.90 -11.20 544.70 490.00 11.16
PBDT 2818.80 1632.80 72.64 2818.80 1632.80 72.64 9753.70 6188.80 57.60
Depreciation 686.80 657.50 4.46 686.80 657.50 4.46 2711.40 2729.50 -0.66
PBT 2132.00 975.30 118.60 2132.00 975.30 118.60 7042.30 3459.30 103.58
TAX 370.10 0.00 0.00 370.10 0.00 0.00 377.50 -8.00 -4818.75
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 1761.90 975.30 80.65 1761.90 975.30 80.65 6664.80 3467.30 92.22
Equity 393.10 393.10 0.00 393.10 393.10 0.00 393.10 393.10 0.00
PBIDTM(%) 19.96 13.33 49.78 19.96 13.33 49.78 17.53 12.97 35.16

Alembic Pharma Share Price

736.95 1.25 (0.17%)
05-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.55
Dr. Reddys Lab 1277.80
Cipla 1400.70
Zydus Lifesciences 1088.90
Lupin 2268.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×